|
2023
|
P/S
|
Therapeutic pharmaceuticals and agents for the treatment of disease, namely, cancer; pharmaceutic... |
|
|
P/S
|
therapeutic pharmaceuticals and agents for the treatment of disease, namely, cancer; pharmaceutic... |
|
2021
|
P/S
|
Therapeutic pharmaceuticals and agents for the treatment of
disease, namely, cancer; pharmaceuti... |
|
2017
|
Invention
|
Crystalline form of compound suppressing protein kinase activity, and application thereof. Provid... |
|
|
Invention
|
Substituted pyridazine carboxamide compounds.
The new pyridazine derivatives have unexpected dru... |
|
2016
|
Invention
|
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds.
Pyridazine derivativ... |
|
2015
|
Invention
|
Substituted pyridazine carboximide compounds.
The new pyridazine derivatives have unexpected dru... |
|
2014
|
Invention
|
Substituted pyridazinecarboxamides as kinase inhibitors. Pyridazine derivatives (e.g., Formula I)... |
|
2011
|
Invention
|
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds. The new pyridazine de... |
|
|
Invention
|
Substituted pyridazine carboxamide compounds. The new pyridazine derivatives have unexpected drug... |
|
2009
|
Invention
|
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds. Pyridazine derivative... |
|
2008
|
Invention
|
Kinase inhibitor compounds. Pyridine and pyridazine derivatives have unexpected drug properties a... |
|
|
Invention
|
Pyridine and pyridazine derivatives as kinase inhibitors. There are provided compounds of formula... |
